Spyre Therapeutics SYRE
NASDAQ SYRE
$104.09 -2.73 (-2.56%)
As of: Nov 12, 2026 · 2:16 PM EST

Spyre Therapeutics (SYRE) Sales of Property, Plant and Equipment (2023)

Updated

Spyre Therapeutics (SYRE) reported Sales of Property, Plant and Equipment of $475,000 for FY2023.

Analysis

Spyre Therapeutics (SYRE) Sales of Property, Plant and Equipment (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Spyre Therapeutics 9.40 Bn 5.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 500,000.00
API Access

Spyre Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=SYRE&period=max&api_key=YOUR_API_KEY